Published January 12, 2018
The biobank is a type of biorepository which stores the biological samples, usually humans for use in future research.These biobanks play a vital role in drug discovery and disease research. Biobanks give access to samples which are collected by doctors for their own research studies. These storages may range from a refrigerator to warehouse, hospitals, universities and pharmaceutical companies.
The Middle East & Africa Biobanks Market Segments Size & Growth:
The Middle East & Africa BiobanksMarket is accounted for $38billion in 2017 and expected to grow at a CAGR of 11% to reach $62 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth due to rapid growth in population increase in chronic diseases, and advancements in biobanking techniques. However, surveillance issues and storage problems hinder the growth of theMiddle East & Africa biobanks market.
The Middle East & Africa Biobanks Market Segments Share:
The Middle East & Africa BiobanksMarket is categorized into by product which consists of consumables, services, equipment, and software. Consumables have the largest share due to the increase in a number of biobanks. On the basis of samples, Biobanksmarket is segmented as biological fluids, human tissues, blood products, and human waste products. Among all human tissues are expected to have high growth rate during the forecast period 2018-2024, because of increase in research. Drug discovery and research are leading in biobanks market among application due to the rise in technological advancements, research, and manufacturing of drugs.
On the basis of Geography, South Africa is dominating the biobanks market and the growth in the Middle East & Africa is mainly attributed because of the increasing demand for personalized medicine and rise in cancer cases. Furthermore, Middle Eastis witnessing the fastest growth during the forecast period, due to rising aging population, chronic diseases and investment in R&D research.
The Middle East & Africa Biobanks Market Segments Trends:
The Middle East & Africa Biobanks Research Report:
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.4 SWOT Analysis
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1.1 Increase in precision medicine
4.1.2 Research and development for clinical trials
4.1.3 Advancement in Biobanks Marketing techniques
4.2.1 Surveillance issues
4.2.2 Problems in storage
4.2.3 Expensive procedures
4.3.1 Research and understanding on various diseases
Chapter 5 Middle East & Africa Biobanks Markets– By Product
Chapter 6 Middle East & Africa Biobanks Markets- By Sample
6.2 Human Tissues
6.3 Blood Products
6.4 Human Waste Products
Chapter 7 Middle East & AfricaBiobanks Markets- By Application
7.1 Life Science Research
7.2 Drug Discovery
7.3 Disease Research
Chapter 8 Middle East & Africa Biobanks Markets- By Geography
8.2 Middle East & Africa
Chapter 9 Middle East & Africa Biobanks Markets- Company Profiles
9.6. Bio Storage Technologies
9.7.DNA Genotek Inc.
9.8.Core Dynamics Ltd.
9.10.Thermo Fisher Scientific Inc.
9.13.Stemcell Technologies Inc.
Chapter 10 Middle East & Africa Biobanks Markets- Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures